Status:
COMPLETED
The Dementia Study in Northern Norway
Lead Sponsor:
University Hospital of North Norway
Collaborating Sponsors:
County Officer of Nordland, Moloveien 2, 8006 Bodø, Norway
Norwegian Foundation for Health and Rehabilitation
Conditions:
Alzheimer Disease
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
The Dementia Study in Northern Norway is an open controled intervention trial carried out in nine rural municipalities, five of which allocated to intervention and four to control. A RCT with donepezi...
Detailed Description
Nine municipalities with 11807 inhabitants 65 years and older were allocated to intervention or control, five and four municipalities in each group, respectively. A panel of psychiatric nurses, univer...
Eligibility Criteria
Inclusion
- Subject aged 65-94 years with a recent diagnosed AD and without any contraindications for the use of donepezil.
- A MMSE sum score has to be at least10 points
Exclusion
- Behavioural disturbance which make cooperation and cognitive testing impossible.
- Individuals with reduced approval competence expressing any reluctance to participate are excluded, as well as those not understanding the purpose of the study and who have relatives or care givers disapproving participation.
- Individuals having a diagnosis of dementia treated with CheI at entry are also excluded.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT00443014
Start Date
June 1 2003
End Date
June 1 2009
Last Update
November 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arran Lulesami Centre
Drag, Nordland, Norway, 8270